Genzyme sues to stop Impax generic drug - San Francisco Business Times PDF Print
San Francisco Business TimesGenzyme Corp. has filed a patent infringement suit against Impax Laboratories Inc. focused on the kidney dialysis drug Renvela. The Hayward-based generic ...Impax Laboratories Confirms Patent Challenge Relating to RENVELA(R), 2.4 g and

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.

Notice: Undefined variable: query in /home/globaldi/public_html/components/com_joomlawatch/class.joomlawatch.db.php on line 129